{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:49:23Z","timestamp":1791499763545,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":271,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["MRF2024363"],"award-info":[{"award-number":["MRF2024363"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["MRF2023250"],"award-info":[{"award-number":["MRF2023250"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["MRF2007605"],"award-info":[{"award-number":["MRF2007605"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["MRF1170276"],"award-info":[{"award-number":["MRF1170276"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["MRF1200254"],"award-info":[{"award-number":["MRF1200254"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.nicl.2026.104075","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:20:12Z","timestamp":1790724012000},"page":"104075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The PSP subcortical atlas - a new neuroimaging atlas for progressive supranuclear palsy Richardson's syndrome"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8430-4824","authenticated-orcid":false,"given":"Cassandra","family":"Marotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0850-3644","authenticated-orcid":false,"given":"Benjamin","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-1991","authenticated-orcid":false,"given":"Meng","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-8621","authenticated-orcid":false,"given":"Terence J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-0907","authenticated-orcid":false,"given":"Lucy","family":"Vivash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2026.104075_bb0005","series-title":"Non-Linear Registration aka Spatial Normalisation FMRIB Technial Report TR07JA2","author":"Andersson","year":"2026"},{"key":"10.1016\/j.nicl.2026.104075_bb0010","series-title":"Medical Image Analysis, Special Issue on The Third International Workshop on Biomedical Image Registration \u2013 WBIR 2006","first-page":"26","article-title":"Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain","volume":"vol. 12","author":"Avants","year":"2008"},{"key":"10.1016\/j.nicl.2026.104075_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117611","article-title":"SEPIA\u2014susceptibility mapping pipeline tool for phase images","volume":"227","author":"Chan","year":"2021","journal-title":"NeuroImage"},{"issue":"8","key":"10.1016\/j.nicl.2026.104075_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/13543784.2022.2087179","article-title":"Investigational therapeutics for the treatment of progressive supranuclear palsy","volume":"31","author":"Coughlin","year":"2022","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.nicl.2026.104075_bb0025","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2026.104075_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.70327","article-title":"Fluid biomarkers of disease burden and cognitive dysfunction in progressive supranuclear palsy","author":"Dilcher","year":"2026","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.nicl.2026.104075_bb0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"Freesurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"NeuroImage"},{"issue":"3","key":"10.1016\/j.nicl.2026.104075_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.nicl.2026.104075_bb0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1176\/appi.ajp.162.7.1256","article-title":"Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder","volume":"162","author":"Frazier","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.nicl.2026.104075_bb0050","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.nicl.2026.104075_bb0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopsych.2006.06.027","article-title":"Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability","volume":"61","author":"Goldstein","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.nicl.2026.104075_bb0060","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/mdc3.70153","article-title":"Magnetic susceptibility and area in the subthalamic nucleus measured by QSM for diagnosis of progressive Supranuclear palsy","volume":"12","author":"Haji","year":"2025","journal-title":"Movement Disord. Clin. Pract."},{"issue":"6","key":"10.1016\/j.nicl.2026.104075_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.nicl.2026.104075_bb0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mds.26973","article-title":"Longitudinal magnetic resonance imaging in progressive supranuclear palsy: a new combined score for clinical trials","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.nicl.2026.104075_bb0075","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.26715","article-title":"Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification","volume":"31","author":"Huppertz","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.nicl.2026.104075_bb0080","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2026.104075_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116619","article-title":"Exploring linearity of deep neural network trained QSM: QSMnet+","volume":"211","author":"Jung","year":"2020","journal-title":"NeuroImage"},{"issue":"4","key":"10.1016\/j.nicl.2026.104075_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4292","article-title":"Overview of quantitative susceptibility mapping using deep learning: current status, challenges and opportunities","volume":"35","author":"Jung","year":"2022","journal-title":"NMR Biomed."},{"issue":"6","key":"10.1016\/j.nicl.2026.104075_bb0095","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00429-016-1352-4","article-title":"Effects of aging on T1, T\u2217 2, and QSM MRI values in the subcortex","volume":"222","author":"Keuken","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.nicl.2026.104075_bb0100","article-title":"Quantitative susceptibility mapping from basal ganglia and related structures: correlation with disease severity in progressive supranuclear palsy","author":"Krishnan","year":"2023","journal-title":"Acta Neurol. Belg."},{"issue":"3","key":"10.1016\/j.nicl.2026.104075_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","article-title":"Automated Talairach atlas labels for functional brain mapping","volume":"10","author":"Lancaster","year":"2000","journal-title":"Hum. Brain Mapp."},{"issue":"11","key":"10.1016\/j.nicl.2026.104075_bb0110","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hbm.20345","article-title":"Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template","volume":"28","author":"Lancaster","year":"2007","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.nicl.2026.104075_bb0115","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.neuroimage.2010.11.088","article-title":"Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition","volume":"55","author":"Li","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2026.104075_bb0120","article-title":"Subcortical tau burden correlates with regional brain atrophy and plasma markers in four-repeat tauopathy parkinsonism","author":"Li","year":"2024","journal-title":"J. Parkinsons Dis."},{"issue":"2\u20133","key":"10.1016\/j.nicl.2026.104075_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2005.11.020","article-title":"Decreased volume of left and total anterior insular lobule in schizophrenia","volume":"83","author":"Makris","year":"2006","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.nicl.2026.104075_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf022","article-title":"Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials","volume":"7","author":"Marotta","year":"2025","journal-title":"Brain Commun."},{"key":"10.1016\/j.nicl.2026.104075_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101999","article-title":"Quantitative susceptibility mapping in atypical Parkinsonisms","volume":"24","author":"Mazzucchi","year":"2019","journal-title":"NeuroImage. Clin."},{"issue":"10","key":"10.1016\/j.nicl.2026.104075_bb0140","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/ene.15447","article-title":"Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms","volume":"29","author":"Mazzucchi","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"17","key":"10.1016\/j.nicl.2026.104075_bb0145","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1002\/hbm.24760","article-title":"Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism","volume":"40","author":"Mitchell","year":"2019","journal-title":"Hum. Brain Mapp."},{"issue":"5","key":"10.1016\/j.nicl.2026.104075_bb0150","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O\u2019Sullivan","year":"2008","journal-title":"Brain"},{"issue":"Pt 2","key":"10.1016\/j.nicl.2026.104075_bb0155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/awv361","article-title":"Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism","volume":"139","author":"Planetta","year":"2016","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.nicl.2026.104075_bb0160","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/mds.29866","article-title":"Magnetic resonance imaging measures to track atrophy progression in progressive supranuclear palsy in clinical trials","volume":"39","author":"Quattrone","year":"2024","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.nicl.2026.104075_bb0165","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/mds.70026","article-title":"Brain atrophy does not predict clinical progression in progressive supranuclear palsy","volume":"40","author":"Quattrone","year":"2025","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.nicl.2026.104075_bb0170","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mds.25327","article-title":"Accuracy of the national institute for neurological disorders and stroke\/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy","volume":"28","author":"Respondek","year":"2013","journal-title":"Mov. Disord."},{"issue":"14","key":"10.1016\/j.nicl.2026.104075_bb0175","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases: PSP diagnostic criteria","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.nicl.2026.104075_bb0180","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/mds.29613","article-title":"Magnetic susceptibility in progressive supranuclear palsy variants, PD and corticobasal syndrome","volume":"38","author":"Satoh","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2026.104075_bb0185","article-title":"Quantitative susceptibility mapping and iron deposition in autopsy-confirmed progressive supranuclear palsy","author":"Satoh","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"9192","key":"10.1016\/j.nicl.2026.104075_bb0190","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nicl.2026.104075_bb0195","doi-asserted-by":"crossref","unstructured":"Schweser, F., Robinson, S., de Rochefort, L., Li, W., & Bredies, K. (2017). An illustrated comparison of processing methods for phase MRI and QSM: removal of background field contributions from sources outside the region of interest. NMR Biomed., 30(4), https:\/\/doi.org\/10.1002\/nbm.3604. doi:10.1002\/nbm.3604.","DOI":"10.1002\/nbm.3604"},{"issue":"3","key":"10.1016\/j.nicl.2026.104075_bb0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction","volume":"17","author":"Smith","year":"2002","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.nicl.2026.104075_bb0205","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00062-018-0727-8","article-title":"Improved automatic morphology-based classification of Parkinson\u2019s disease and progressive supranuclear palsy","volume":"29","author":"Talai","year":"2019","journal-title":"Clin. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.104075_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.648548","article-title":"Utility of multi-modal MRI for differentiating of Parkinson\u2019s disease and progressive Supranuclear palsy using machine learning","volume":"12","author":"Talai","year":"2021","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.nicl.2026.104075_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055019","article-title":"Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial","volume":"11","author":"Vivash","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.nicl.2026.104075_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2013.00027","article-title":"Multi-atlas segmentation with joint label fusion and corrective learning\u2014an open source implementation","volume":"7","author":"Wang","year":"2013","journal-title":"Front. Neuroinform."},{"key":"10.1016\/j.nicl.2026.104075_bb0225","article-title":"Hybrid tau-PET\/MRI study: quantitative susceptibility mapping in progressive supranuclear palsy and its correlation with Tau-PET","author":"Weih","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.nicl.2026.104075_bb0230","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.nicl.2026.104075_bb0235","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2026.104075_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroimage.2018.06.030","article-title":"Quantitative susceptibility mapping using deep neural network: QSMnet","volume":"179","author":"Yoon","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2026.104075_bb0245","article-title":"Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders","volume":"14","author":"Zhang","year":"2022","journal-title":"Front. Aging Neurosci."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221315822600135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221315822600135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:51:07Z","timestamp":1791496267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221315822600135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"alternative-id":["S221315822600135X"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2026.104075","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PSP subcortical atlas - a new neuroimaging atlas for progressive supranuclear palsy Richardson's syndrome","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2026.104075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104075"}}